Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase Ia/Ib Trial of 2nd Generation Anti-CEA Designer T Cells in Metastatic Breast Cancer

NCT00673829 is registered in ClinicalTrials.gov with Roger Williams Medical Center as lead sponsor.

NCT NCT00673829
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00673829 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase Ia/Ib Trial of 2nd Generation Anti-CEA Designer T Cells in Metastatic Breast Cancer
Lead sponsor
Roger Williams Medical Center
Phase
Phase 1
Overall status
Suspended
Start date
May 31, 2008
Completion date
December 31, 2018
Enrollment
26 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer